BURLINGTON, Ontario–(BUSINESS WIRE)–Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) announces that further to the review by the Ontario Securities Commission (“OSC”) of the Company’s continuous disclosure record, and a subsequent request from staff of the OSC in connection therewith, the Company has filed corrective disclosure with respect to the following documents: management’s … [Read more…]
LOS ANGELES–(BUSINESS WIRE)–#COVID19–A Washington Post investigation has revealed an ambitious effort by China to expand its biotechnology sector significantly, with sometimes controversial research, to keep up with (or overtake) the U.S. and other Western powers while failing to ensure adequate safety measures kept pace. AIDS Healthcare Foundation (AHF) urges China or any nation conducting research … [Read more…]
BURLINGTON, Ontario–(BUSINESS WIRE)–Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE), a Canadian biotechnology company leveraging an innovative, proprietary oral delivery platform, is announcing changes to its board of directors. Jason Lewis has resigned as a director of the Company. We thank him for his three years of service as a director. Mr. Lewis … [Read more…]
U.S. Senator Katie Britt (R-Ala.) presented the Engage Woman Award for Non-Profit Leadership to Brooke and Breanna Bennett at Engage’s Remarkable Women Reception and Dinner in Washington, D.C. WASHINGTON–(BUSINESS WIRE)–Brooke and Breanna Bennett, Co-Founders of Women in Training, Inc. (WIT), were recognized on March 28 for their tremendous advocacy work – helping to create and … [Read more…]
OXFORD, England & MARCY-L’ETOILE, France–(BUSINESS WIRE)–Oxford Nanopore Technologies plc (LSE: ONT) (“Oxford Nanopore”), the company delivering a new generation of nanopore-based molecular sensing technology, and bioMérieux SA, a world leader in the field of in vitro diagnostics, today announced that they have teamed up to improve health outcomes globally by exploring selected opportunities to bring … [Read more…]
Findings validate clinical proof of mechanism of MTL-CEBPA as a combination therapy in solid tumor cancers Company to initiate out-licensing activities of its immuno-oncology portfolio, including MTL-CEBPA LONDON–(BUSINESS WIRE)–MiNA Therapeutics Limited, the pioneer in small activating RNA (RNAa) therapeutics, will present positive updated biomarker data from its Phase 1a/b TIMEPOINT study of MTL-CEBPA in combination … [Read more…]
– Phase 1 data show encouraging clinical benefit for IO-108 as a monotherapy and when combined with pembrolizumab, suggesting potential to overcome resistance to T-cell checkpoint inhibitors – – Preclinical data for IO-312, a novel bispecific antibody targeting LILRB4 (ILT3) and CD3 (LILRB4 x CD3) will be presented as a late-breaking poster at AACR 2023 … [Read more…]
Funding will accelerate commercial launch of DefineMBC™ SAN DIEGO–(BUSINESS WIRE)–Epic Sciences, Inc. (“Epic” or “Epic Sciences”), a privately held diagnostics company, has completed a $24 million Series G which together with its $43 million Series F financing, totals $67 million raised in the last twelve months. The company will use the capital from this additional … [Read more…]
New Poll Finds 87% of Respondents Support Regulating PBMs SALEM, Ore.–(BUSINESS WIRE)–With the Beaver State already facing negative impacts of harmful business practices by pharmacy benefit managers (PBMs), a new poll among likely Oregon voters finds that an overwhelming majority support policy proposals to require these middlemen health insurance companies to lower drug costs and … [Read more…]
Davenport alumnus donation created new wellness center on campus; developing two new mental health degree programs GRAND RAPIDS, Mich.–(BUSINESS WIRE)–Davenport University has announced a $1 million gift from the Klingenberg Family, given specifically to fund a new wellness center on its W.A. Lettinga Campus in Grand Rapids and support the development of two new Mental … [Read more…]
